Related Experiment Videos

[Treatment of obstetric cholestasis with polyunsaturated phosphatidylcholine and ursodeoxycholic acid]

Beata Marciniak1, Zaneta Kimber-Trojnar, Bozena Leszczyńska-Gorzelak

  • 1Katedra i Klinika Poloinictwa i Perinatologii Uniwersytetu Medycznego w Lublinie.

Ginekologia Polska
|April 9, 2011
PubMed

Insights

This study on obstetric cholestasis found that higher bile acid levels correlate with earlier diagnosis and more severe outcomes. Combined therapy with UDCA and PPC may be beneficial, especially for early-onset or severe cases.

Area of Science:

  • Obstetrics and Gynecology
  • Hepatology
  • Perinatal Medicine

Background:

  • Obstetric cholestasis is a serious pregnancy complication characterized by elevated bile acids.
  • Understanding the relationship between bile acid levels and obstetric outcomes is crucial for timely intervention.
  • Current treatment strategies for obstetric cholestasis vary, necessitating research into optimal therapeutic approaches.

Purpose of the Study:

  • To analyze obstetric outcomes and laboratory results in relation to pre-treatment serum bile acid (BA) levels in patients with obstetric cholestasis.
  • To compare the efficacy of different treatment regimens (PPC, UDCA, or combination) based on BA levels.
  • To investigate the correlation between BA levels and indicators of cholestasis severity and pregnancy progression.

Main Methods:

  • A cohort of 43 pregnant women diagnosed with obstetric cholestasis was divided into three groups based on pre-treatment serum bile acid (BA) levels (11-15, 15-20, and >20 micromol/L).
  • Group I received polyunsaturated phosphatidylcholine (PPC), Group II received ursodeoxycholic acid (UDCA), and Group III received a combination of UDCA and PPC.
  • Maternal serum levels of transaminases, alkaline phosphatase, bilirubin, and bile acids were measured before treatment and during delivery. Cord blood BA levels were also assessed.

Main Results:

  • No significant differences were observed in patient age, parity, delivery method, birth weight, or Apgar scores across groups.
  • The group with the highest pre-treatment bile acid levels (>20 micromol/L) exhibited the earliest diagnosis of obstetric cholestasis.
  • This severe group also showed earlier pregnancy termination, higher pre-treatment transaminases and bile acids, and greater fluctuations in these markers compared to the lowest BA group.

Conclusions:

  • Combined therapy with UDCA and PPC appears to be a promising treatment option for obstetric cholestasis.
  • This combined approach may be particularly beneficial in cases of early-onset or severe obstetric cholestasis.
  • Further research is warranted to confirm the efficacy and optimal use of combined UDCA and PPC therapy.
Abstract

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Synthesis of Phosphatidylcholine in the ER Membrane01:27

Synthesis of Phosphatidylcholine in the ER Membrane

The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...